col0,col1,col2,col3,col4,col5,col6,col7
adalimumab,Humira,immunologic factor,Adalimumab,2.9,ulcerative colitis,Australian pregnancy category C,chemical compound
infliximab,Remsima,dermatologic drug,Infliximab,3.75,Takayasu's arteritis,Australian pregnancy category C,chemical compound
Natalizumab,Natalizumab Elan Pharma,immunologic factor,Natalizumab,10,multiple sclerosis,Australian pregnancy category C,chemical compound
adalimumab,Humira,immunologic factor,Adalimumab,2.9,reactive arthritis,Australian pregnancy category C,chemical compound
denosumab,Prolia,bone density conservation agents,Denosumab,0.33,bone fracture,Australian pregnancy category D,biopharmaceutical
